LIVECAST Markets Briefs Calendar Search

Research

AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Briefs Calendar Search AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive Account

Live News EARNINGS FLASH L impact Sep 29, 2026, 01:34 PM UTC

SmartStop Self REIT Sees FY26 Adj FFO $1.99-$2.05/Shr >SMA

SquawkNews Newsroom

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

SMA

Related stories

Smartstop Self Storage Raises FY2026 FFO Guidance from $1.98-$2.04 to $1.99-$2.05 vs $1.99 Est Smartstop Self Storage (NYSE: SMA ) raises FY2026 FFO guidance from $1.98-$2.04 to $1.99-$2.05 vs $1.99 analyst estimate.. H impact | LIVE | Sep 29, 2026, 02:27 PM UTC Superior Plus Announces Timing of 2026 Third Quarter Results Conference Call and Webcast Superior Plus Corp. (“Superior” or “the company”) (TSX:SPB) expects to release its 2026 third quarter results on Tuesday, November 10, 2026, after market. A conference call and web L impact | EARNINGS | Sep 29, 2026, 02:27 PM UTC Miquel y Costas H1 net profit €18.7 million 7m, net sales €156.0m and EBITDA €35.1m. M impact | EARNINGS | Sep 29, 2026, 02:20 PM UTC Sterling Little Moved After U.K. PM Burnham Speech — Market Talk Sterling shows little reaction after U.K. Prime Minister Andy Burnham announced plans to reform pensions in a speech Tuesday, as widely expected. From 2030 the government will adju H impact | EARNINGS | Sep 29, 2026, 02:20 PM UTC Novo Nordisk says Ozempic 2 mg cuts major cardiovascular event risk vs Mounjaro Novo Nordisk said real-world analysis at EASD found Ozempic (semaglutide) 2 mg was linked to a 6% lower risk of major cardiovascular events versus switching to Mounjaro (tirzepatid M impact | EARNINGS | Sep 29, 2026, 02:15 PM UTC IOVA Stock Hits Over 2-Year Highs — Why Iovance Raised Its FY2026 Revenue Outlook Shares of Iovance Biotherapeutics (IOVA) surged to their highest levels in more than two years on Tuesday, after the biotech firm raised its full-year revenue outlook, citing stron L impact | EARNINGS | Sep 29, 2026, 02:15 PM UTC

SQUAWK/NEWS

Live financial news for traders. Read the headline on screen or hear it through LiveCast while you stay on the trade.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

Product

Open LiveCast
Plans & Pricing
Institutional API
How LiveCast Works
Live Markets
Session Briefs
RSS Feed
Calendar
Search
Instrument directory

Research

Macro
Politics
Prediction Markets
AI Market Assistant
News Archive

For Traders

Market Movers
US Stocks
Why News Moves Markets
News for Traders
How to Trade the News
What Is an Audio Squawk?
Policy Calendar

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

Legal

Privacy Policy
Terms of Use

© 2026 SquawkNews SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.